NIH assesses third COVID-19 vaccine dose in kidney transplant recipients – ET HealthWorld

By Manojna Maddipatla The U.S. National Institutes of Health (NIH) said on Tuesday it had launched a new study to assess how patients on immunosuppressive therapy after kidney transplant, who did not respond to the first two doses of COVID-19 vaccine, respond to a third dose. The study, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), aims to determine whether a third dose of either Moderna or Pfizer/BioNTech COVID-19 vaccine could help kidney transplant patients overcome the problem of not developing immune response to the coronavirus even…

Read More